Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7032463rdf:typepubmed:Citationlld:pubmed
pubmed-article:7032463lifeskim:mentionsumls-concept:C0007226lld:lifeskim
pubmed-article:7032463lifeskim:mentionsumls-concept:C0035237lld:lifeskim
pubmed-article:7032463lifeskim:mentionsumls-concept:C0031634lld:lifeskim
pubmed-article:7032463lifeskim:mentionsumls-concept:C0037473lld:lifeskim
pubmed-article:7032463pubmed:issue3lld:pubmed
pubmed-article:7032463pubmed:dateCreated1982-2-12lld:pubmed
pubmed-article:7032463pubmed:abstractTextIn the dog, rat and chick, phosphocreatine-Na has not caused, from an experimental point of view, significative modifications of the cardiovascular- and respiratory-apparatus, of the reactivity of the cardio-regulator centers, of the baroreceptorial carotid-sinus and glomus reactivity, of the gangliar-, muscarinic-, histaminergic-, dopaminergic-, beta-adrenergic- and serotoninergic- vasomotor reactivity; only the vasomotor reactivity of a constrictive-type induced by epinephrine, nor-epinephrine, occlusion of the two common carotid arteries, hypertension and by BaCl2 is moderately reduced. It is interesting to note that the hypotensive response evoked by adenosine was augmented.lld:pubmed
pubmed-article:7032463pubmed:languageitalld:pubmed
pubmed-article:7032463pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7032463pubmed:citationSubsetIMlld:pubmed
pubmed-article:7032463pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7032463pubmed:statusMEDLINElld:pubmed
pubmed-article:7032463pubmed:issn0004-0312lld:pubmed
pubmed-article:7032463pubmed:authorpubmed-author:MarmoEElld:pubmed
pubmed-article:7032463pubmed:authorpubmed-author:LampaEElld:pubmed
pubmed-article:7032463pubmed:authorpubmed-author:GiasiMMlld:pubmed
pubmed-article:7032463pubmed:authorpubmed-author:ImperatoreAAlld:pubmed
pubmed-article:7032463pubmed:authorpubmed-author:PernaDDlld:pubmed
pubmed-article:7032463pubmed:authorpubmed-author:OttavoRRlld:pubmed
pubmed-article:7032463pubmed:authorpubmed-author:VisoneCClld:pubmed
pubmed-article:7032463pubmed:authorpubmed-author:SommaAAlld:pubmed
pubmed-article:7032463pubmed:authorpubmed-author:PierriTTlld:pubmed
pubmed-article:7032463pubmed:authorpubmed-author:MateraGGlld:pubmed
pubmed-article:7032463pubmed:authorpubmed-author:RuggieroEElld:pubmed
pubmed-article:7032463pubmed:issnTypePrintlld:pubmed
pubmed-article:7032463pubmed:volume138lld:pubmed
pubmed-article:7032463pubmed:ownerNLMlld:pubmed
pubmed-article:7032463pubmed:authorsCompleteYlld:pubmed
pubmed-article:7032463pubmed:pagination365-98lld:pubmed
pubmed-article:7032463pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:7032463pubmed:meshHeadingpubmed-meshheading:7032463-...lld:pubmed
pubmed-article:7032463pubmed:meshHeadingpubmed-meshheading:7032463-...lld:pubmed
pubmed-article:7032463pubmed:meshHeadingpubmed-meshheading:7032463-...lld:pubmed
pubmed-article:7032463pubmed:meshHeadingpubmed-meshheading:7032463-...lld:pubmed
pubmed-article:7032463pubmed:meshHeadingpubmed-meshheading:7032463-...lld:pubmed
pubmed-article:7032463pubmed:meshHeadingpubmed-meshheading:7032463-...lld:pubmed
pubmed-article:7032463pubmed:meshHeadingpubmed-meshheading:7032463-...lld:pubmed
pubmed-article:7032463pubmed:meshHeadingpubmed-meshheading:7032463-...lld:pubmed
pubmed-article:7032463pubmed:meshHeadingpubmed-meshheading:7032463-...lld:pubmed
pubmed-article:7032463pubmed:meshHeadingpubmed-meshheading:7032463-...lld:pubmed
pubmed-article:7032463pubmed:meshHeadingpubmed-meshheading:7032463-...lld:pubmed
pubmed-article:7032463pubmed:articleTitle[Sodium phosphocreatine and the cardiovascular and respiratory systems].lld:pubmed
pubmed-article:7032463pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:7032463pubmed:publicationTypeEnglish Abstractlld:pubmed
pubmed-article:7032463pubmed:publicationTypeReviewlld:pubmed